Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

March 15, 2019

FDA Grants Accelerated Approval to Tecentriq-Abraxane Combo for Some TNBC

News

The U.S. Food and Drug Administration has granted accelerated approval to a combination of Tecentriq (atezolizumab) and the chemotherapy Abraxane (nab-paclitaxel) for patients with advanced triple-negative breast cancer, making this ... Read more

March 6, 2019

Imaging Agent May Provide Early Info About Benefits of Hormone Therapies for Breast Cancer

News

A new imaging agent that successfully measures changes in progesterone receptor (PR) levels may be used to determine if a breast cancer patient will respond to hormone therapies targeting ... Read more

February 27, 2019

Sacituzumab Govitecan Shinks Tumors in One of Three Metastatic TNBC Patients, Trial Shows

News

One in three women with metastatic triple-negative breast cancer — all of whom had received at least two prior treatments — saw their tumors shrink after receiving Immunomedics‘ investigational treatment sacituzumab govitecan as ... Read more

February 11, 2019

Margetuximab Helps to Delay Disease Progression in Advanced, HER2-positive Breast Cancers, Phase 3 Trial Shows

News

A combination of MacroGenics‘ HER2 antibody margetuximab and standard chemotherapy is superior to Herceptin (trastuzumab) plus chemotherapy at extending the time to disease progression among advanced and pre-treated breast cancer patients whose ... Read more

October 24, 2018

Sermonix Launches Phase 2 Trial Testing Lasofoxifene in Advanced Breast Cancer Patients with ER Mutations

News

Sermonix is launching a Phase 2 trial to determine if its lead investigational medicine lasofoxifene is better than Faslodex (fulvestrant) at delaying disease progression or death in breast cancer patients ... Read more

June 15, 2018

Talazoparib, Potential Treatment for Metastatic Breast Cancer with BRCA Mutations, Up for US and EU Approval

News

The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have agreed to review Pfizer’s application for talazoparib, a candidate for the treatment of metastatic breast cancer in ... Read more

June 6, 2018

Parenting Concerns Significantly Affect Emotional Well-being of Mothers with Advanced Cancer, Study Finds

News

Parenting concerns are a major factor contributing to the psychological distress of women with late-stage cancer, and are associated with a lower quality of life, a study has found. ... Read more

April 30, 2018April 30, 2018

Risk of Cancer Outcomes Worsens When Patients Wait for Diagnostic Tests, Study Finds

News

Cancer patients who wait longer from a positive screening result to a diagnostic test have a higher risk for worse outcomes, according to researchers who reviewed cancer studies. The ... Read more

April 11, 2018April 11, 2018

New Screening Guidelines Recognize High Breast Cancer Risk in African-American Women

News

New breast cancer screening guidelines recognize for the first time that African-American women are at high risk for breast cancer and should be screened accordingly. The guidelines, published by the American College ... Read more

April 2, 2018

More Men Should Be in Breast Cancer Trials to Improve Their Treatment, Expert Asserts

News

More men should be included in breast cancer trials to try to improve treatment for them, a British expert contends. Robert Mansel, an emeritus professor at Wales’ Cardiff University School of ... Read more

Pin It on Pinterest